Huabing Zhang

机构：Anhui Medical University, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Michigan Medicine, First Affiliated Hospital of Anhui Medical University, Yancheng Teachers University · ORCID：0000-0001-8402-7830

发表论文 73 篇 · 总被引 2482 次 · h-index 24

代表论文

• Roles of immune dysregulation in MASLD (2023 · Biomedicine & Pharmacotherapy · 被引 38)
• Hepatic Zbtb18 (Zinc Finger and BTB Domain Containing 18) alleviates hepatic steatohepatitis via FXR (Farnesoid X Receptor) (2024 · Signal Transduction and Targeted Therapy · 被引 25)
• Epigenetic reader ZMYND11 noncanonical function restricts HNRNPA1-mediated stress granule formation and oncogenic activity (2024 · Signal Transduction and Targeted Therapy · 被引 22)
• CBX2 Deletion Suppresses Growth and Metastasis of Colorectal Cancer by Mettl3-p38/ERK MAPK Signalling Pathway (2024 · Journal of Cancer · 被引 14)
• Association of glucagon-like peptide-1 receptor agonist use with risk of infections: A systematic review and meta-analysis (2025 · Journal of Infection · 被引 12)
• Robust machine−learning based prognostic index using cytotoxic T lymphocyte evasion genes highlights potential therapeutic targets in colorectal cancer (2024 · Cancer Cell International · 被引 12)